Axsome Therapeutics (AXSM) Equity Ratio (2022 - 2025)
Historic Equity Ratio for Axsome Therapeutics (AXSM) over the last 4 years, with Q3 2025 value amounting to 0.11.
- Axsome Therapeutics' Equity Ratio fell 3341.92% to 0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.11, marking a year-over-year decrease of 3341.92%. This contributed to the annual value of 0.1 for FY2024, which is 6910.91% down from last year.
- According to the latest figures from Q3 2025, Axsome Therapeutics' Equity Ratio is 0.11, which was down 3341.92% from 0.11 recorded in Q2 2025.
- Over the past 5 years, Axsome Therapeutics' Equity Ratio peaked at 0.46 during Q3 2022, and registered a low of 0.08 during Q2 2022.
- For the 4-year period, Axsome Therapeutics' Equity Ratio averaged around 0.24, with its median value being 0.19 (2024).
- In the last 5 years, Axsome Therapeutics' Equity Ratio surged by 44149.66% in 2023 and then plummeted by 6910.91% in 2024.
- Axsome Therapeutics' Equity Ratio (Quarter) stood at 0.33 in 2022, then fell by 1.77% to 0.32 in 2023, then crashed by 69.11% to 0.1 in 2024, then grew by 9.84% to 0.11 in 2025.
- Its Equity Ratio stands at 0.11 for Q3 2025, versus 0.11 for Q2 2025 and 0.09 for Q1 2025.